20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
SUBCUTANEOUS ADMINISTRATION OF AN ASBT INHIBITOR
#3002PARENTERAL UNIT DOSAGE FORM OF DIHYDROERGOTAMINE
#3003COMBINATION CHEMO-IMMUNOTHERAPY FOR PANCREATIC CANCER USING THE IMMUNOGENIC EFFECTS OF AN IRINOTECAN SILICASOME NANOCARRIER PLUS ANTI-PD-1
#3004TREATMENT OF CANCER USING A SMAD3 INHIBITOR
#3005BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS
#3006Biodegradable polymer microsphere compositions for parenteral administration
#3007Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#3008CETRORELIX INJECTABLE LIQUID FORMULATION
#3009Injectable slurries and methods of manufacturing the same
#3010METHOD OF TREATING CANCER
#3011Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocytes Derived from Vector Transduced HSCS for Therapy of Disorders
#3012Stromal stem cells
#3013METHODS FOR TREATING SHORT BOWEL SYNDROME AND/OR HIGH OUTPUT OSTOMY
#3014Methods of treating AL amyloidosis
#3015AAV-MEDIATED EXPRESSION OF ANTI-INFLUENZA ANTIBODIES AND METHODS OF USE THEREOF
#3016Lipid nanoparticle compositions and methods for mRNA delivery
#3017HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
#3018SENSITISER FOR CANCER TREATMENT
#3019Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
#3020METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE
#3021METHODS OF TREATING SYSTEMIC GRAFT- VERSUS-HOST DISEASE WITH EXTRACELLULAR VESICLES
#3022APPLICATION OF MESENCHYMAL STEM CELLS IN PREPARATION OF DRUG FOR REPAIRING LUNG DAMAGE CAUSED BY COVID-19
#3023BLOOD-BRAIN BARRIER-PENETRATING NANOTHERANOSTICS FOR ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES AND THE LIKE
#3024CARBON NANOPARTICLES SUSPENSION INJECTION-FE MIXTURE AS WELL AS PREPARATION METHOD
#3025METHODS FOR THE TREATMENT OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS
#3026A NON-AQUEOUS SUSPENSION OF ANTICANCER AGENT
#3027Methods for treating pulmonary non-tuberculous mycobacterial infections
#3028Treatment of breast cancer using combination therapies comprising an ATP competitive AKT inhibitor, a CDK4/6 inhibitor, and fulvestrant
#3029USE OF FENOLDOPAM FOR THE TREATMENT OF HEMOLYTIC UREMIC SYNDROME
#3030Biodegradable polymer formulations for extended efficacy of botulinum toxin
#3031Levodopa infusion solution
#3032RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)
#3033Stromal stem cells
#3034Method for preparing acylated crosslinked glycosaminoglycans
#3035Early intervention methods to prevent or ameliorate toxicity
#3036MODEL FOR PREDICTION OF TOLERABILITY ISSUES IN CONNECTION WITH INTRAVENOUS ADMINISTRATION OF THERAPEUTIC ANTIBODIES
#3037EGFR x CD28 MULTISPECIFIC ANTIBODIES
#3038Near infrared fluorescent dyes, formulations and related methods
#3039Modulators of PCSK9 Expression
#3040PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#3041USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
#3042Dosage Regimen for a Controlled-Release PTH Compound
#3043Medicine for Preventing or Treating Symptom or Disorder in Subject Affected by Viral Infection
#3044Intrathecal Delivery of Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2
#3045IONIZING IRRADIATION STERILIZATION OF BACTERIAL MINICELL-BASED BIOPHARMACEUTICALS AND METHODS OF USE
#3046METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF
#3047Therapeutically active compounds and their methods of use
#3048ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF
#3049Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
#3050Methods To Treat Cancer With AMXT 1501 and DFMO
#3051USE OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG FOR DIAGNOSING AND TREATING BREAST CANCER
#3052PHYTONADIONE COMPOSITIONS
#3053Stromal stem cells
#3054METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES
#3055FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY
#3056Method of Treating Psoriasis with IL-23 Specific Antibody
#3057SYSTEMS AND METHODS TO IMPROVE VACCINE EFFICACY
#3058MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS
#3059NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF
#3060APPARATUS AND METHOD FOR PRODUCING AN ENRICHED MEDICAL SUSPENSION OF CARBON DIOXIDE
#3061ROCURONIUM BROMIDE PREFILLED SYRINGE
#3062METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
#3063GENE THERAPIES FOR LYSOSOMAL DISORDERS
#3064FACTOR IX POLYPEPTIDE FORMULATIONS
#3065POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF
#3066Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids
#3067Emulsion, Injection Agent, and Emulsion Preparation Method
#3068INJECTABLE ARIPIPRAZOLE FORMULATION
#3069USE OF CASPASE INHIBITOR FOR ALLEVIATING OR TREATING OSTEOARTHRITIS
#3070INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#3071Stable pharmaceutical compositions of bendamustine
#3072Compositions And Methods For Treating Autism
#3073CULTIVATION OF PLACENTA TO ISOLATE EXOSOMES
#3074COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION
#3075Compositions and methods for delivery of AAV
#3076METHODS OF TREATING NEW-ONSET PLAQUE TYPE PSORIASIS USING IL-17 ANTAGONISTS
#3077METHODS FOR REDUCING MIGRAINE FREQUENCY IN A SUBJECT IN NEED THEREOF
#3078INTRATUMORAL VACCINATION
#3079TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#3080NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)
#3081RADIOLABELED DARAPLADIB AND ANALOGS THEREOF AND THEIR USE AS IMAGING COMPOUNDS
#3082Coronavirus vaccine
#3083HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION
#3084INCREASING THE EFFICACY OF BIOLOGICAL THERAPEUTIC MOLECULES
#3085METHODS FOR THE PREVENTION OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS
#3086Therapeutic agent for nervous system disease
#3087METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE
#3088Pharmaceutical Compositions and Methods for Stabilizing the Same
#3089Ready-to-administer hydromorphone formulations
#3090Tiglien-3-one derivatives
#3091Storage stable aqueous parenteral solutions comprising diclofenac
#3092USE OF PHENOL IN TREATMENT OF MICROBIALLY INDUCED DYSPNOEA
#3093LIPOSOMIC DRUG-DELIVERY VEHICLES
#3094BIOCOMPATIBLE, INJECTABLE AND IN SITU GELLING HYDROGELS AND PREPARATION AND APPLICATIONS OF BIOCOMPATIBLE, INJECTABLE AND IN SITU GELLING HYDROGELS BASED ON CELLULOSE NANOFIBRILS FOR TISSUE AND ORGAN REPAIR
#3095USE OF IL-22 DIMER IN MANUFACTURE OF A MEDICAMENT FOR INTRAVENOUS ADMINISTRATION
#3096PERSISTENT HSV GENE DELIVERY SYSTEM
#3097METHODS AND COMPOSITIONS FOR TREATMENT OF FRAGILE X SYNDROME
#3098PH20 polypeptide variants, formulations and uses thereof
#3099PH20 polypeptide variants, formulations and uses thereof
#3100Antiplatelet drugs and uses thereof
#3101BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES
#3102[161 tb]-based radiopeptides
#3103GENE EDITING-BASED METHOD OF ATTENUATING THE BETA-AMYLOID PATHWAY
#3104LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#3105CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM
#3106Coronavirus vaccine
#3107MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
#3108Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
#3109Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#3110Ready-to-use bivalirudin compositions
#3111Compositions and methods for improving gastrointestinal function
#3112METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS
#3113PHARMACEUTICAL COMPOSITION OF AQUAPORIN INHIBITOR AND PREPARATION METHOD THEREOF
#3114INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CYCLODEXTRIN, A HYDROPHOBIC DRUG, A CO-SOLVENT AND A PRESERVATIVE
#3115INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS
#3116Enhanced penetration ophthalmic compositions of bimatoprost and timolol
#3117METHODS OF TREATING OPHTHALMIC CONDITIONS WITH ENHANCED PENETRATION COMPOSITIONS OF BIMATOPROST AND TIMOLOL
#3118ANTICOAGULANT COMPOUNDS, METHODS AND DEVICES FOR OPHTHALMIC USE
#3119USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#3120INJECTABLE DEPOT FORMULATION COMPRISING CARIPRAZINE FREE BASE PARTICLES
#3121Methods and compositions for treatment of epileptic disorders
#3122Methods and compositions for treatment of epileptic disorders
#3123METHOD OF INITIATING SOTALOL HYDROCHLORIDE DOSING
#3124RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES
#3125BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#3126SUGAR-COATED MELANIN NANOPARTICLES AND METHOD FOR TARGETING METASTATIC CANCER CELLS
#3127METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
#3128NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME
#3129PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#3130GENE THERAPIES FOR LYSOSOMAL DISORDERS
#3131PD-L1/LAG-3 BISPECIFIC ANTIBODY FORMULATION AND PREPARATION METHOD THEREFOR AND USE THEREOF
#3132USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE
#3133Production of biosimilar ustekinumab in CHO cells
#3134METHODS FOR TREATING ATOPIC DERMATITIS AND RELATED DISORDERS
#3135PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF MICRORNA RELATED DISEASES
#3136Delivery device
#3137Lipid nanoparticle compositions and methods for MRNA delivery
#3138Lipid nanoparticle compositions and methods for MRNA delivery
#3139FORMULATIONS OF BENDAMUSTINE
#3140Targeting Microbubbles
#3141EFFICACIOUS MRNA VACCINES
#3142COMPOSITIONS AND METHODS FOR TREATING MYOCARDIAL INFARCTION AND ISCHEMIA
#3143TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA
#3144RECONSTITUTABLE TEVERELIX-TFA COMPOSITION
#3145MIXTURES AND FORMULATIONS
#3146Methods for the prevention or treatment of heart failure
#3147THERAPEUTIC AGENT FOR NERVE DAMAGE
#3148NANOPARTICLES FOR CANCER TREATMENT
#3149COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#3150Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin
#3151Pharmaceutical use of (E)-3-arylheterocyclylprop-2-enoic acid derivatives
#3152THERAPEUTIC FORMULATIONS AND USES THEREOF
#3153Specialized pro-resolving mediators (SPMs) as melanocyte growth promoter and pro-survival factors and uses thereof
#3154LONG ACTING ANTICANCER COMPOSITIONS
#3155EPINEPHRINE FORMULATIONS
#3156Biomarkers for Efficacy of Prophylactic Treatments Against Stress-Induced Affective Disorders
#3157PHARMACEUTICAL COMPOSITION OF INTRA-ARTICULAR CORTICOSTEROID FOR PAIN CONTROL
#3158METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
#3159METHODS OF TREATMENT OF CANCER BY CONTINUOUS INFUSION OF COENZYME Q10
#3160VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS
#3161Adeno-associated virus variant capsids and methods of use thereof
#3162METHODS AND COMPOSITIONS FOR INCREASING ALPHA-L-IDURONIDASE ACTIVITY IN THE CNS
#3163ANTI-TETRODOTOXIN ANTIBODY C31K8, AND PREPARATION METHOD AND USE THEREOF
#3164ANTI-TETRODOTOXIN ANTIBODY K548, AND PREPARATION METHOD AND USE THEREOF
#3165ANTI-IL2 RECEPTOR GAMMA ANTIGEN-BINDING PROTEINS
#3166COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
#3167Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
#3168FUSION PROTEIN COMPRISING A BLOOD-BRAIN BARRIER (BBB)-CROSSING SINGLE DOMAIN ANTIBODY FC5, AN IMMUNOGLOBULIN FC FRAGMENT AND A BETA-AMYLOID BINDING POLYPEPTIDE (ABP)
#3169GENE THERAPY WITH DYSFERLIN DUAL VECTORS
#3170HYALURONIC ACID BASED FORMULATIONS
#3171CONFORMAL COATING OF CELLS FOR IMMUNOISOLATION
#3172GENE THERAPY
#3173PHARMACEUTICAL COMPOSITION FOR THE PARENTERAL ADMINISTRATION OF ULTRASHORT-EFFECTIVE BETA-ADRENORECEPTOR ANTAGONISTS
#3174METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS
#3175Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
#3176Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
#3177Engineered chimeric fusion protein compositions and methods of use thereof
#3178WHOLE-CELL CANCER VACCINES AND METHODS FOR SELECTION THEREOF
#3179Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)
#3180VEILLONELLA PARVULA STRAIN AS AN ORAL THERAPY FOR NEUROINFLAMMATORY DISEASES
#3181Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
#3182METHOD OF TREATMENT FOR PSILOCYBIN OR PSILOCIN INFUSION
#3183COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#3184USES OF BUPIVACAINE MULTIVESICULAR LIPOSOMES AS STELLATE GANGLION BLOCK
#3185SIROLIMUS MICROSPHERES AND METHOD OF MAKING SIROLIMUS MICROSPHERES
#3186Methods for treating cardiovascular diseases
#3187INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
#3188Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
#3189SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODY
#3190Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody
#3191COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER
#3192Method of treating cancer using disulfide-linked trimeric OX40L
#3193Formulation, Dosage Regimen, and Manufacturing Process for Heterodimeric FC-Fused Proteins
#3194INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER
#3195DOFETILIDE DRUG DOSING METHODS AND SYSTEMS AND PRESCRIPTION DRUG USE RELATED SOFTWARE
#3196GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP
#3197MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC)
#3198EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#3199USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
#3200Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site
#3201INJECTION COMPOSITION CONTAINING ISOLATED MITOCHONDRIA, AND USE THEREOF
#3202METHODS OF TREATMENT USING FUROSEMIDE
#3203PREPARATION METHOD OF SALFAPRODIL FREEZE-DRIED POWDER INJECTION, AND PRODUCT AND USE THEREOF
#3204COMBINATION OF MEDICATIONS IN A PARENTERAL DOSAGE FORM FOR LONG-TERM ANAESTHESIA
#3205METHODS OF TREATING PHELAN MCDERMID SYNDROME USING FARNESYL DIBENZODIAZEPINONES
#3206Compositions and methods for opioid antagonist delivery
#3207Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction
#3208THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#3209Compositions and methods of treating cardiac fibrosis with ifetroban
#3210INTRATHECAL ADMINISTRATION OF LEVETIRACETAM
#3211SALVINORIN COMPOSITIONS
#3212LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF
#3213TARGETED DELIVERY OF EXTRACELLULAR VESICLES
#3214ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING REGULATED AND CONTROLLED BY MICRORNA AND USE THEREOF
#3215Anti-TMPRSS2 antibodies and antigen-binding fragments
#3216T cell-antigen coupler with Y182T mutation and methods of uses thereof
#3217LAG-3 ANTAGONIST THERAPY FOR HEPATOCELLULAR CARCINOMA
#3218RECOMBINANT HUMAN EPO-FC-FUSION PROTEINS WITH PROLONGED HALF-LIFE AND ENHANCED ERYTHROPOIETIC ACTIVITY IN VIVO
#3219ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS
#3220ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
#3221DENDRIMER-DRUG CONJUGATE
#3222METHODS TO STIMULATE HLA-AGNOSTIC IMMUNE RESPONSES TO PROTEINS USING NUCLEATED CELLS
#3223FORMATION OF BONE
#3224COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS, COMPRISING MESENCHYMAL STEM CELL EXPRESSING TUMOR NECROSIS FACTOR-INDUCIBLE GENE 6
#3225Method for prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin
#3226CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION
#3227METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#3228THERAPY OF POST-OPERATIVE NAUSEA AND VOMITING
#3229Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
#3230COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN
#3231POLY(ETHYLENE GLYCOL)-BLOCK-POLY(PROPYLENE SULFIDE) NANOCARRIER PLATFORM FOR ENHANCED EFFICACY OF IMMUNOSUPPRESSIVE AGENTS
#3232ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#3233Compositions and methods for inhibiting expression of transthyretin
#3234CANCER TREATMENT
#3235CIS-Binding Siglec Agonists and Related Compositions And Methods
#3236High concentration anti-C5 antibody formulations
#3237T-cell modulatory multimeric polypeptides and methods of use thereof
#3238METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES
#3239METHOD FOR PREPARING ATOMIZING SARS-COV-2 NANOVACCINE
#3240RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF
#3241SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS
#3242COMPOSITIONS, METHODS AND USES COMPRISING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE -1 (TCAP-1) FOR ENHANCING MUSCLE PERFORMANCE
#3243VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
#3244Treatment of warts
#3245PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES
#3246METHODS OF USING PULMONARY CELLS FOR TRANSPLANTATION AND INDUCTION OF TOLERANCE
#3247Chlorite In the Treatment of Acute Respiratory Distress Syndrome
#3248Sodium nitrite-containing pharmaceutical compositions
#3249ARIPIPRAZOLE INJECTABLE SUSPENSION FORMULATION HAVING PROLONGED SHELF LIFE
#3250PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF TISSUE INJURY
#3251CDC7 kinase inhibitors and uses thereof
#3252TREPROSTINIL PRODRUGS
#3253METHODS OF ADMINISTERING DOFETILIDE
#3254METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE
#3255Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#3256PH20 polypeptide variants, formulations and uses thereof
#3257SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES
#3258Therapeutic variant alpha-2-macroglobulin compositions
#3259ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
#3260Controlled-release PTH compound
#3261Lipid formulations for delivery of therapeutic agents
#3262Nucleoside-modified RNA for Inducing an Immune Response Against SARS-CoV-2
#3263Treatment of Limb Spasticity
#3264Liquid Formulation of a VEGF Antagonist
#3265INJECTABLE COMPOSITION COMPRISING GnRH ANALOGUE
#3266Therapeutic bacteriophage compositions for treating infection
#3267Methods of Identifying Novel Dosing Regimens
#3268Pharmaceutical compositions of testosterone
#3269Dosage regimen of paliperidone palmitate extended-release injectable suspension
#3270USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#3271Methods of treatment
#3272Long Acting Injectable Formulations
#3273LENALIDOMIDE PRODRUGS, POLYMERIC CONJUGATES, AND FORMULATIONS THEREOF, AND THEIR USES FOR THE TREATMENT OF MULTIPLE MYELOMA
#3274Intravenous baclofen formulations and treatment methods
#3275METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE
#3276METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER
#3277CONCENTRATED INJECTABLE TRANEXAMIC ACID COMPOSITIONS AND METHODS OF USE THEREOF
#3278INJECTABLE HIGH-DRUG-LOADED NANOCOMPOSITE GELS AND PROCESS FOR MAKING THE SAME
#3279Treating refractory migraine
#3280CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF
#3281Materials and methods for treating Friedreich's Ataxia
#3282LIPID COMPOUND AND THE COMPOSITION THEREOF
#3283Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations
#3284Biocampatible and Biodegradable Anionic Hydrogel System
#3285RNA PARTICLES COMPRISING POLYSARCOSINE
#3286FORMULATIONS OF BENDAMUSTINE
#3287Treatment of severe community acquired pneumonia
#3288mRNA VACCINE DESIGN USING MULTIPLE INTERACTING IMMUNO-STIMULATORY PATHWAYS, FOR CANCER AND INFECTIOUS DISEASES
#3289Composition comprising an algal proteoglycan extract and use thereof
#3290METHODS OF TREATING DISEASE WITH TERLIPRESSIN
#3291Adeno-associated virus formulations
#3292Treatment of bone marrow pathologies with polysulfated polysaccharides
#3293Hydroxypropyl beta-cyclodextrin compositions and methods
#3294Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
#3295Methods Of Treating Cancer Using Prmt5 Inhibitors
#3296Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics
#3297Targeting papain-like protease for broad-spectrum coronaviruses inhibition
#3298Methods of treatment
#3299LONG-ACTING FORMULATIONS
#3300RAPAMYCIN (RAPA) SELF-MICROEMULSIFYING INJECTION AND PREPARATION METHOD AND USE THEREOF